Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Clin Res Cardiol ; 109(5): 531-538, 2020 May.
Article in English | MEDLINE | ID: covidwho-7790


BACKGROUND: Studies have reminded that cardiovascular metabolic comorbidities made patients more susceptible to suffer 2019 novel corona virus (2019-nCoV) disease (COVID-19), and exacerbated the infection. The aim of this analysis is to determine the association of cardiovascular metabolic diseases with the development of COVID-19. METHODS: A meta-analysis of eligible studies that summarized the prevalence of cardiovascular metabolic diseases in COVID-19 and compared the incidences of the comorbidities in ICU/severe and non-ICU/severe patients was performed. Embase and PubMed were searched for relevant studies. RESULTS: A total of six studies with 1527 patients were included in this analysis. The proportions of hypertension, cardia-cerebrovascular disease and diabetes in patients with COVID-19 were 17.1%, 16.4% and 9.7%, respectively. The incidences of hypertension, cardia-cerebrovascular diseases and diabetes were about twofolds, threefolds and twofolds, respectively, higher in ICU/severe cases than in their non-ICU/severe counterparts. At least 8.0% patients with COVID-19 suffered the acute cardiac injury. The incidence of acute cardiac injury was about 13 folds higher in ICU/severe patients compared with the non-ICU/severe patients. CONCLUSION: Patients with previous cardiovascular metabolic diseases may face a greater risk of developing into the severe condition and the comorbidities can also greatly affect the prognosis of the COVID-19. On the other hand, COVID-19 can, in turn, aggravate the damage to the heart.

Betacoronavirus , Cardiovascular Diseases/complications , Coronavirus Infections , Metabolic Syndrome/complications , Pandemics , Pneumonia, Viral , Cardiovascular Diseases/epidemiology , China , Coronavirus Infections/complications , Coronavirus Infections/epidemiology , Humans , Metabolic Syndrome/epidemiology , Pneumonia, Viral/complications , Pneumonia, Viral/epidemiology , Prevalence